Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.49 |
| ▸ | MEN1 | O00255 | 6/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4089380 | 0.89 | ALDH1A1 (0.61) | ALDH1A1GLATSHRRAB9ASMN1; SMN2 | |
| SCHEMBL9267264 | 0.86 | ALDH1A1 (0.56) | ALDH1A1GLATSHRRAB9ASMN1; SMN2 | |
| SCHEMBL25271701 | 0.85 | ALDH1A1 (0.53) | ALDH1A1GLATSHRRAB9ASMN1; SMN2 | |
| SCHEMBL5652301 | 0.78 | LIPE (0.54) | ALDH1A1GLATSHRRAB9ASMN1; SMN2 | |
| SCHEMBL10781340 | 0.78 | LTB4R2 (0.46) | ALDH1A1GLARAB9ASMN1; SMN2NPC1 | |
| SCHEMBL11428311 | 0.77 | ALDH1A1 (0.50) | ALDH1A1GLATSHRRAB9ASMN1; SMN2 | |
| SCHEMBL11422493 | 0.76 | ATM (0.56) | ALDH1A1GLATSHRRAB9ASMN1; SMN2 | |
| SCHEMBL7653262 | 0.75 | ALDH1A1 (0.66) | ALDH1A1GLATSHRSMN1; SMN2KMT2A | |
| SCHEMBL5881193 | 0.75 | TSHR (0.66) | ALDH1A1GLATSHRSMN1; SMN2KMT2A | |
| SCHEMBL340272 | 0.75 | ALDH1A1 (0.70) | ALDH1A1GLATSHRSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090259062-A1 | SURFACTANT COMPOSITIONS AND ASSOCIATED METHOD | MOMENTIVE PERFORMANCE MATERIALS INC. | 2009-10-15 | — | — | US | disclosed |
| US-7601680-B2 | Gemini silicone surfactant compositions and associated methods | MOMENTIVE PERFORMANCE MATERIALS (US) | 2009-10-13 | — | — | US | disclosed |
| US-20070134283-A1 | Surfactant-based composition and associated methods | GENERAL ELECTRIC COMPANY (US) | 2007-06-14 | — | — | US | disclosed |
| US-20070135329-A1 | Surfactant compositions and associated method | GENERAL ELECTRIC COMPANY (US) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090259062-A1 | SURFACTANT COMPOSITIONS AND ASSOCIATED METHOD | SGMS2, SGMS1, GMNN | ALDH1A1 3934/4885GLA 1045/4885TSHR 2757/4885 |
| US-20070134283-A1 | Surfactant-based composition and associated methods | SGMS2, SGMS1, GEMIN4 | ALDH1A1 3686/4885GLA 292/4885TSHR 2471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.